Mantle Cell Lymphoma (MCL) Recruiting Phase 2 Trials for Ixazomib (DB09570)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Recruiting2 IdentifierTitlePurposeDrugs
NCT03616782Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)Treatment
NCT02339922Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin LymphomaTreatment